We studied the alterations in myocardial ,-adrenergic receptoradenylate cyclase activity and muscarinic receptor density in a canine model of left ventricular (LV) failure. LV failure was characterized by a doubling of LV weight/body weight ratio (3.3±0.1 to 6.9±0.4 g/kg) and an elevation of LV end-diastolic pressure, 32±4.5 mmHg, compared with 7.7±0.6 mmHg in normal dogs. Despite a 44% increase in receptor density as measured by antagonist binding studies with 13Hldihydroalprenolol, there was a twofold decrease in receptor affinity, i.e., an increase in the dissociation constant (Kd) (5.6±0.7 to 12±1.6 nM) in heart failure. Agonist displacement of 13Hjdihydroalprenolol binding with isoproterenol in the presence and absence of 5'-guanylylimidodiphosphate [Gpp(NH)pl demonstrated a striking loss of high affinity binding sites in heart failure (51±16 to 11±5%). fl-Adrenergic receptor-mediated stimulation of adenylate cyclase and maximal stimulation with Gpp(NH)p or sodium fluoride was reduced in heart failure. There was a concomitant marked, P < 0.01, reduction in muscarinic receptor density (242±19 vs. 111±20 fmol/mg). Thus, while muscarinic receptor density fell, ,8-adrenergic receptor density actually increased in LV failure. However, a larger portion of the ,8-adrenergic receptors are not functionally coupled to the GTP-stimulatory protein (N.), as evidenced by a decrease in the fraction of receptors that bind agonist with high affinity.
Introduction
Several disorders of autonomic cardiovascular control have been described in experimental animals and patients with heart failure (1-3). It is conceivable that the mechanism of altered autonomic control of the heart involves changes in receptor regulation. While little is known regarding changes in muscarinic receptors, two prior studies have examined fl-adrenergic receptor regulation in heart failure, but have reported divergent results. Karliner et al. (4) found increased f3-adrenergic receptor number in a guinea pig heart failure model, whereas Bristow et al. (5) found the reverse in end stage heart failure in man. It is important to note that no prior study has systematically evaluated the changes in fl-adrenergic receptor density and affinity, using agonist and an-tagonist ligand binding studies in combination with ffieasurement of adenylate cyclase activity in an experimental large mammalian model of left ventricular (LV)' failure.
The goal of this investigation was to examine fl-adrenergic and muscarinic receptor regulation in dogs with pressure overload-induced LV failure. The advantages of this model are the spontaneous development of LV failure, and the gradual development of the LV pressure overload lesion over one year.
Furthermore, not only was f3-adrenergic receptor number and adenylate cyclase activity quantitated, but also receptor-cyclase coupling was examined by calculating the fraction ofthe receptor population in a high affinity state for agonists from isoproterenol competition curves in the presence and absence of 5'-guanylylimidodiphosphate [Gpp(NH)p].
Methods
Mongrel puppies of either sex at 7-10-wk-old were anesthetized with sodium thiamylal (10 mg/kg), maintained with halothane (1 vol %), and ventilated with an animal respirator (Harvard Apparatus Co., Inc., S. Natick, MA). A right thoracotomy was performed through the fourth intercostal space using sterile surgical technique. The (13) . Plasma samples were drawn before killing. Tissue samples were taken from the mid-anterior free wall of the LV at the time of killing and placed in liquid nitrogen. Na+,K+-ATPase activity was determined according to the method of Jones and Besch (6) . The protein concentrations for each membrane assay were determined by the method of Lowry et al. (14) .
The affinity for isoproterenol in the presence and absence of0. 1 (.) and in the heart with LV failure (*). The LV failure heart shows a lower affinity and more receptors per milligram protein than the normal LV. The insert shows a saturation plot of the same data. Bound ifmol//mg protein Figure 2 . Scatchard analyses of muscarinic, cholinergic receptor antagonist binding to LV membranes are compared in the normal heart (-) and in the heart with LV failure (*). A decrease in receptors per milligram protein is apparent in the failing heart. The inset shows a saturation plot of the same data.
fmol/mg, n = 6, P < 0.01) compared with the values obtained in the control group (242±19 fmol/mg, n = 6) (Fig. 2) (Fig. 4) . A dose response curve for adenylate cyclase stimulation by isoproterenol with GTP (0.1 mM) using a purified sarcolemma preparation is shown in Fig. 5 . The maximal response was threefold higher in the normal LV. Other membrane markers. Na',K+-ATPase activity of myocardial membranes, another membrane-associated protein that is uninvolved in ligand recognition, was used as a reference for the 3-adrenergic receptor. The plasma membrane-associated activity of Na',K+-ATPase was 2.8±0.1 grmol Pi/h per mg protein (n = 7) in the normal LV. In LV failure preparations, Na',K+-ATPase activity was less, 2.0±0.2 ,qmol P/h per mg protein (n = 6). Thus, the increase in f3-adrenergic receptor density in the LV failure membranes did not reflect an alteration in the membrane preparation between control and heart failure animals. Norepinephrine levels. In the LV failure animals, LV tissue norepinephrine (221±77 pg/mg) was depressed (P < 0.02) (n = 6) compared with LV values (473±58 pg/mg) in the nine normal dogs in which it was measured. Plasma norepinephrine was higher in the animals with LV failure (505±96 vs. 290±20 pg/ ml) (P < 0.05).
Discussion
Defects in autonomic regulation of the failing heart have been noted for some time (2, 3, 17) . The most frequent and impressive finding has been a reduction in catecholamine stores (18) (19) (20) . This occurs in the hypertrophied heart (7), but is more severe in LV failure. In contrast, in chronic heart failure, plasma levels of norepinephrine are elevated (21) . The present investigation indicates that several alterations in the 3-adrenergic receptorcyclase system also occur in heart failure.
First, as with the state of hypertrophy before the development of LV decompensation (7) , ,B-adrenergic receptor number increased, and a decreased affinity for [3H]DHA was again apparent. Although the increase in receptor number could be a secondary adjustment to a depletion of local catecholamine stores, it is difficult to reconcile the persistent alteration in antagonist affinity. That this phenomenon is not some artifact ofthe binding procedure employed is underscored by our recent studies using identical biochemical techniques in the canine heart after chronic surgical denervation. In this model, we demonstrated that an increase in receptor number of similar magnitude occurs without any alteration in affinity for [3H]DHA (10) . These observations suggest that the receptor protein expressed in the left ventricle of animals with LV hypertrophy and failure may differ from those of normal animals, similar to the expression of new gene products for a variety of myocardial proteins, including myosin (22) , creatine phosphokinase (23) , and lactate dehydrogenase (24, 25) Previous work has demonstrated that the f3-adrenergic receptor can exist in two affinity states for agonists (26, 27) . It is the high affinity form ofthe receptor that is functionally coupled to the GTP-stimulating protein (NJ), and thus has been considered to be the physiologically relevant form of the receptor. To determine which form of the receptor exists in the dogs with LV failure, agonist competition curves were generated in the presence and absence of Gpp(NH)p. In the absence of guanylyl nucleotides, the curve is more shallow and can be modeled by two sites , KL and KH, for isoproterenol. With the addition of Gpp(NH)p, which converts all the receptors into KL, the curve shifts to the right, becomes steeper, and follows a typical mass action relationship for a single site of KL. Computer modeling of these curves demonstrated major differences between normal and failure animals. In Fig. 3 , it is apparent that in the absence of Gpp(NH)p, the competition curve generated with the membranes from failing hearts is steeper and shifted to the right when compared with the curves derived from normal hearts. The pooled experimental data indicate that only 11% of the total receptor population is in a "coupled" or high affinity state in the heart failure animals, as compared with 5 1% for the normal animals.
This finding of a decrease of fl-adrenergic receptors in the high affinity state suggests that catecholamines have a reduced ability to trigger an appropriate inotropic response for any given number of agonist-occupied receptors in the hearts of animals with LV failure. This finding may be important in understanding the mechanism of depressed inotropic and chronotropic responses to sympathetic nerve activation in heart failure. Whereas prior studies have suggested that this was due to reduced innervation and catecholamine stores (17, 28) , the current data would also implicate a postsynaptic mechanism.
It is possible that this alteration represents a state of receptor desensitization whereby an uncoupling of the receptor from the effector protein, N,, has been promoted (29) . It is important to note, however, that the total receptor number was actually increased in heart failure in this study, a finding that would not have been predicted in a state of increased catecholamine exposure. Furthermore, this increase in receptor number was not a nonspecific effect observed with other membrane proteins, since Na',K+-ATPase activity was not elevated in heart failure.
A second possible explanation for the loss in high affinity receptors is suggested by our finding that in heart failure the affinity of the receptor for [3H]DNA is altered. As noted above, if the receptor protein itself were different, this may also be reflected in a decreased ability ofthe receptor to form a high affinity interaction with N,.
A third potential mechanism underlying the observed reduction in the fraction of high-affinity receptors in heart failure is a deficiency or abnormality of the GTP-coupling protein. So-dium fluoride and Gpp(NH)p both require N, for cyclase stimulation. This finding of decreased cyclase activity together with a reduction in the number of high affinity or "coupled" receptors implies that N, could be functionally deficient in the hearts of failure animals. Further inquiry into this possibility could be undertaken by the development of reconstitution protocols designed to assess the functional level of N,. Such an abnormality occurs in one form of pseudohypoparathyroidism, where a decreased concentration of high affinity agonist-binding sites in erythrocytes has been documented (30), as well as in certain other pathophysiological states such as hypothyroidism, (31) or after adrenalectomy, (32) where abnormalities in f3-adrenergic receptor function were found to occur with a decrease in the concentration of high-affinity agonist binding sites.
The muscarinic, cholinergic receptor, another plasma membrane-bound receptor, was studied to see if the changes in fladrenergic receptor density were specific or if other receptors were altered in a similar manner. In contrast to the results for f3-adrenergic receptor density, which rose, muscarinic receptor number was reduced by 50% in the LV with heart failure. It is possible that the decrease in muscarinic receptor density may be due to a loss of sympathetic prejunctional neurons in heart failure, resulting in a loss of associated muscarinic receptors located prejunctionally, as may occur with cardiac denervation (10) . Again, it should be emphasized that the changes in muscarinic receptor density occurred in a direction opposite from the fl-adrenergic receptor. Finally, it might be speculated that the decrease in muscarinic receptor density may be involved in the mechanism of altered parasympathetic control of the failing heart (1-3). In summary, this study has demonstrated in a chronic canine model of LV hypertrophy and failure that an uncoupling of the ,8-receptor occurs, as evidenced by a decrease in the number of receptors that bind agonist with high affinity. Further evidence is provided to suggest that this is not the sole result of a desensitization process secondary to increased catecholamine exposure. Subsequent biochemical studies will be required to determine whether the receptor protein itself, the GTP-regulatory protein, or some other membrane component(s) is primarily responsible for the observed alterations in /3-adrenergic receptor function.
